WAVEMAN · COMPANY

HNGE · Hinge Health, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

HNGE

Name: Hinge Health, Inc. (HNGE) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Hinge Health, Inc.

SOFTWARE & IT · SERVICES-COMPUTER PROCESSING & DATA PREPARATION · CIK 0001673743

FORM 144 · 19☆ WATCH

INSIDER NET · 180D

-$303.9M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

198

13F, latest reported quarter

REVENUE GROWTH

+50.6%

XBRL, annual

NET MARGIN

-89.9%

CONVERSIONS · 180D

codes C/M, not in net · $0 priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$303.9M over 180 days

-$274.0M over 90 days · -$272.8M of it by a 10%+ holder

below 97% of Software & IT

CONGRESS

no member of Congress has reported trading it

FUNDS

198 funds added or opened last quarter

more than 73% of Software & IT

REVENUE

+50.6% year over year

more than 87% of Software & IT

MARGIN

-89.9% net margin

below 86% of Software & IT

BUYBACKS

$131.5M repurchased, FY to 2026-06-30

more than 63% of Software & IT

SHORT

4.0 days to cover · settled 2026-07-31

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$303.9M across 9 people in 180 days.

198 funds added or opened positions in the latest 13F quarter, of 279 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +63.0%

+63.0%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $303.9M sold by insiders over 180 days, 198 funds added last quarter, $306.7M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TEAM META CRWV CRM NET CRWD DDOG DASH APP IOT PCTY MDB

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Hinge Health, Inc. insiders sold a net $303.9M of stock across 144 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Leslie Kristina M

Director

SELL

2026-08-20

1,200.0

$105.9K

Insight Holdings Group, LLC

—

SELL

2026-07-09

87,848.0

$7.9M

Insight Holdings Group, LLC

—

SELL

2026-07-09

2,090.0

$188.5K

Insight Holdings Group, LLC

—

SELL

2026-07-09

72,036.0

$6.5M

Insight Holdings Group, LLC

—

SELL

2026-07-09

13,935.0

$1.3M

144 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 139 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

3,570,131.0 sh

$296.3M

11.2 Capital Management, LLC

2,464,657.0 sh

$204.6M

VANGUARD PORTFOLIO MANAGEMENT LLC

2,146,032.0 sh

$178.1M

Deer Management Co. LLC

1,908,707.0 sh

$158.4M

VANGUARD CAPITAL MANAGEMENT LLC

1,892,834.0 sh

$157.1M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Michael Triplett 2012 Irrevocable Trust.

FILED 2026-09-03

$1.2M

Lieberman Jeffrey

FILED 2026-09-01

$1.0M

Jeffrey Lieberman 2012 Family Trust

FILED 2026-09-01

$26.7K

JL 2025 Family Trust LLC

FILED 2026-09-01

$754.4K

Triplett Thomas Michael

FILED 2026-08-28

$6.0M

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Meridian Small Cap Growth Fund

$5.2M POSITION · AS OF 2026-03-31

2.2%

Osterweis Opportunity Fund

$6.1M POSITION · AS OF 2026-03-31

2.1%

Meridian Growth Fund

$9.1M POSITION · AS OF 2026-03-31

1.9%

AVE MARIA WORLD EQUITY FUND

$2.3M POSITION · AS OF 2026-03-31

1.7%

Baron Technology ETF

$2.1M POSITION · AS OF 2026-03-31

1.5%

Royce Smaller-Companies Growth Fund

$2.4M POSITION · AS OF 2026-03-31

1.3%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 5 registered trials, 3 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

3 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12
REVENUE	$587.9M	$390.4M	$292.7M
GROSS PROFIT	$468.2M	$299.9M	$194.2M
OPERATING INCOME	$-546.4M	$-31.9M	$-130.5M
NET INCOME	$-528.3M	$-11.9M	$-108.1M
EPS (DILUTED)	-7.77	-0.88	-8.31
OPERATING CASH FLOW	$171.4M	$49.0M	$-63.9M
CASH	$208.0M	$300.8M	$235.0M
BUYBACKS	$65.0M	$0	$0

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE